GSK Continues Buyback With £10.9m Treasury Share Purchase

GlaxoSmithKline ( (GB:GSK) ) has issued an update.

GSK plc has repurchased 500,000 of its ordinary shares on 2 March 2026 through BNP Paribas, at a volume‑weighted average price of 2,180.14p, with the shares to be held in treasury as part of its ongoing buyback programme. Since 17 February 2026, GSK has bought back 4,636,000 shares in total, leaving 4,071,635,394 shares in issue and 244,527,094 held in treasury, representing 6.01% of voting rights and modestly enhancing the relative stake of remaining shareholders.

The transaction updates investors on GSK’s capital management strategy and confirms the current total voting rights, a key reference for regulatory disclosure thresholds under the Financial Conduct Authority’s transparency rules. By continuing to retire shares into treasury, the company signals confidence in its valuation and returns surplus capital to investors, potentially supporting earnings per share over time.

The most recent analyst rating on (GB:GSK) stock is a Sell with a £17.00 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GB:GSK Stock Forecast page.

Spark’s Take on GB:GSK Stock

According to Spark, TipRanks’ AI Analyst, GB:GSK is a Neutral.

The score is driven primarily by strong profitability and improving recent fundamentals, supported by constructive 2026 guidance and pipeline momentum. Valuation is reasonable with a modest yield, while the main constraint is technical overbought risk and ongoing balance-sheet/earnings-consistency considerations.

To see Spark’s full report on GB:GSK stock, click here.

More about GlaxoSmithKline

GSK plc is a global biopharmaceutical company focused on developing and manufacturing medicines and vaccines. Listed in London, it operates across major therapeutic areas and is a constituent of the U.K. blue-chip equity indices, with an active capital allocation policy that includes share buybacks.

Average Trading Volume: 9,035,821

Technical Sentiment Signal: Buy

Current Market Cap: £88.73B

For an in-depth examination of GSK stock, go to TipRanks’ Overview page.